arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Greenwich LifeSciences, Inc.

GLSI

$17.43 ▼ -2.04 (-10.48%) at close

31 Visible periods

17 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Greenwich LifeSciences, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $254.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -101.9% ↘

FCF / Share $-0.13 ↗

Trailing P/E —

Price / Book 82.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

31-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-5.66M

↓ -73.6% —

FCF / Share Free cash flow per share

$-0.13

↑ +58.9% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -4349.7% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.51x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	10.0% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-56.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-31.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-252.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-53.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-11.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	4.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-5.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-116.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-13.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-22.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-73.6% Weak ↓ Weak Declining Year-over-year change in net income	-73.6% Weak ↓ Weak Declining Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	-31.7% Weak ↑ Weak Improving Year-over-year change in net income	-31.7% Weak ↑ Weak Improving Year-over-year change in net income	-31.7% Weak ↑ Weak Improving Year-over-year change in net income	-251.9% Weak ↓ Weak Declining Year-over-year change in net income	-16.4% Weak ↓ Weak Declining Year-over-year change in net income	-16.4% Weak ↓ Weak Declining Year-over-year change in net income	-16.4% Weak ↓ Weak Declining Year-over-year change in net income	1.6% Caution ↑ Caution Improving Year-over-year change in net income	-7.9% Weak ↑ Weak Improving Year-over-year change in net income	-7.9% Weak ↑ Weak Improving Year-over-year change in net income	-7.9% Weak ↑ Weak Improving Year-over-year change in net income	-18.2% Weak ↑ Weak Improving Year-over-year change in net income	-229.9% Weak ↓ Weak Declining Year-over-year change in net income	-229.9% Weak ↓ Weak Declining Year-over-year change in net income	-229.9% Weak ↓ Weak Declining Year-over-year change in net income	-105.1% Weak ↑ Weak Improving Year-over-year change in net income	-144.0% Weak ↑ Weak Improving Year-over-year change in net income	-144.0% Weak → Weak Stable Year-over-year change in net income	-144.0% Weak ↑ Weak Improving Year-over-year change in net income	-242.0% Weak Weak Year-over-year change in net income	-64.5% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-131.8% Weak Weak Year-over-year change in free cash flow	—	—	—	-0.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-101.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1777.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-150.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-222.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-197.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-844.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	19.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-45.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-128.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-109.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-129.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-119.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-237.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-46.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-46.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-1261.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-181.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1310%)	-107.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-816%)	—	-149.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1094%)	-226.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1609%)	-248.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1755%)	—	-49.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-431%)	-42.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-48.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-422%)	-41.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	-24.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-20.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-10.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-2.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-114%)	-2.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-114%)	-2.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-4.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	16.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	17.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	24.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+66%)	12.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	—	—	$-6.18M	$-3.81M	$-3.13M	$-2.75M	$-4.09M	$-5.82M	$-7.22M	$-5.51M	$-6.99M	$-9.14M	$-10.94M	$-11.91M	$-13.47M	$-15.64M	$-17.19M	$-19.74M	$-27.20M	$-28.91M	$-29.80M	$-30.40M	$-28.66M	$-6.21M	—	—	$-6.83K	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.27	$-0.39	$-0.58	$-0.30	$-0.30	$-0.25	$-0.74	$-0.20	$-0.20	$-0.19	$-0.21	$-0.19	$-0.13	$-0.17	$-0.22	$-0.18	$-0.06	$-0.15	$-0.18	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.13	$-0.32	—	$-0.20	—	$-0.14	—	—	—	$-0.14	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.21	$0.36	$0.02	$0.16	$0.11	$0.10	$0.07	$0.38	$0.45	$0.40	$0.52	$0.69	$0.83	$0.91	$1.03	$1.20	$1.33	$1.51	$2.04	$2.19	$2.26	$2.32	$2.18	$0.39	—	—	$-0.16	—	—	—	—
Tangible Book Value per Share (USD)	$0.21	$0.36	$0.02	$0.16	$0.11	$0.10	$0.07	$0.38	$0.45	$0.40	$0.52	$0.69	$0.83	$0.91	$1.03	$1.20	$1.33	$1.51	$2.04	$2.19	$2.26	$2.32	$2.18	$0.39	—	—	$-0.16	—	—	—	—
Basic Weighted Avg Shares (shares)	14.62M	14.57M	—	13.64M	13.37M	13.17M	—	13.14M	12.91M	12.86M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$3.12M	$5.27M	$353.22K	—	—	—	$906.85K	—	—	—	—	—	—	—	—	—	—	—	—	$28.45M	$29.15M	$29.73M	—	$4.64M	—	—	$-1.37M	—	—	—	—
Total Equity (USD)	$3.12M	$5.27M	$353.22K	$2.18M	$1.44M	$1.31M	$908.63K	$4.98M	$5.88M	$5.12M	$6.70M	$8.85M	$10.65M	$11.68M	$13.21M	$15.41M	$16.97M	$19.51M	$26.83M	$28.46M	$29.16M	$29.75M	$27.63M	$4.66M	$-1.46M	$-1.42M	$-1.35M	$-1.21M	$-12.87M	$-10.27M	$-10.12M

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Income, GAAP (USD)	$-5.66M	$-5.66M	$-7.92M	$-3.26M	$-3.26M	$-3.26M	$-9.67M	$-2.47M	$-2.47M	$-2.47M	$-2.75M	$-2.12M	$-2.12M	$-2.12M	$-2.79M	$-1.97M	$-1.97M	$-1.97M	$-2.36M	$-597.01K	$-597.01K	$-597.01K	$-1.15M	$-244.64K	$-244.64K	$-244.64K	$-336.54K	$-148.73K	—	—	—
Operating Cash Flow (USD)	$-1.94M	$-4.70M	$-3.17M	$-2.67M	—	$-1.83M	$-1.85M	—	—	$-1.78M	$-2.15M	—	—	$-1.56M	$-2.17M	—	—	$-1.95M	$-2.26M	—	—	$-528.27K	—	—	—	—	$-214.17K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 31 quarters

Greenwich LifeSciences, Inc.

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare GLSI with peers